Monday, October 18, 2021

AZ, Daiichi Sankyo’s Enhertu wins US approval for HER2-positive gastric cancer




AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval in the US for the treatment of locally advanced/metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma.

The approval will make Enhertu available to adult patients with these cancer types who have received a prior trastuzumab-based regimen.

The US Food and Drug Administration (FDA) approval is based on results from the Phase III DESTINY-Gastric01 trial.

This study evaluated Enhertu versus chemotherapy  (irinotecan or paclitaxel) in patients with advanced gastric cancer or GEJ who had progressed on at least two or more prior regimens.

In this trial, patients treated with Enhertu had a 41% reduction in the risk of death versus patients treated with chemotherapy, with median overall survival of 12.5 months versus 8.4 months.

Results also showed a confirmed overall response rate (ORR) of 40.5% in patients treated with Enhertu compared to 11.3% for patents treated with chemotherapy.

Patients treated with Enhertu had a 7.9% complete response rate and a 32.5% partial response rate compared to a complete response rate of 0% and a partial response rate of 11.3% for patients treated with chemotherapy.

“Today’s approval of Enhertu represents the first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer,” said Dave Fredrickson, executive vice president, oncology business unit at AZ.

“The results from the DESTINY-Gastric01 trial highlight the potential to change clinical practice, showing a 41% improvement in survival and a response rate more than three times higher with Enhertu compared to chemotherapy. We are thrilled to bring this important medicine to more patients and physicians in the US,” he added.



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...